slides · global inventory
Quote
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 18,554
Current window 1,171-1,200
Pages 619
Rows per page 30
Component
1,171-1,200 of 18,554
03
The slide uses a 'villain' narrative technique by juxtaposing critical expert opinion with aggressive sales tactics and controversial industry associations.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes4 hits
28
The slide uses direct quotes from medical professionals to undermine the competitive advantage of the subject drug (Wakix).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment4 hits
264
Includes direct quotes from the physician regarding his clinical experience and frustrations with insurance paperwork.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
280
The slide highlights potential regulatory/compliance risks (lack of monitoring) and commercial opacity (pricing) regarding the drug Wakix.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
318
The slide uses direct quotes to expose potential unethical sales practices and reliance on key opinion leaders (KOLs) in the pharmaceutical industry.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
339
The slide uses direct quotes to highlight operational inefficiencies and potential lack of transparency in the patient services process.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
352
The slide uses highlighted text to emphasize key allegations of regulatory non-compliance and unethical sales practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
361
The slide uses highlighted text to emphasize key claims about PIPs and quota misalignment.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
137
The slide uses direct quotes to frame IonQ's technology as inferior to its competitor, Honeywell.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 4 hits
157
The slide uses direct quotes to frame the deal as a 'sham' and 'backscratching' to meet revenue targets.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 4 hits
158
The slide uses direct quotes from a former executive to highlight internal confusion and cynicism regarding company processes.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 4 hits
166
Uses an analogy (AMD/Intel) to frame the contradiction.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 4 hits
175
The slide uses direct quotes from industry experts to undermine the credibility of the company's leadership structure.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 4 hits
128
The slide uses direct quotes to frame Lasertec as unreliable and unsuitable for production, positioning KLA as the desired alternative.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
227
The slide presents qualitative feedback from an industry expert, highlighting specific technical failures (uptime, debris, UI) and risks associated with the 'Urashima' light source.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
291
The slide presents expert testimony defending KLA's non-actinic inspection technology against competitors.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
18
The slide uses a testimonial-heavy format to undermine the company's official narrative regarding sales force attrition and product performance.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The MonsterLoop · The Reveal4 hits
23
The slide uses yellow highlighting to emphasize critical claims about the CEO's lack of engagement and the company's underlying performance issues.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle4 hits
28
The slide uses a 'villain critique' approach by citing external authorities to undermine the company's product efficacy and business ethics.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle4 hits
30
The slide uses expert quotes to undermine the company's clinical claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle4 hits
33
The slide uses highlighted text to emphasize specific claims about tolerance and pathological changes.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle4 hits
60
Uses direct quotes to undermine the credibility of the company's primary clinical evidence.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction4 hits
61
The slide uses highlighted text to emphasize key accusations regarding the validity of the 10kHz frequency and the integrity of the clinical trial data.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory4 hits
65
The slide uses anecdotal evidence from public review sites to attack the character of a key study investigator.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory4 hits
68
The slide uses yellow highlighting to emphasize key phrases within the quotes, such as 'rigged' and 'manipulated the patients'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory4 hits
71
Uses highlighted quotes to build a case against the company's core technology claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory4 hits
73
The slide uses testimonials to undermine the company's core product claim.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory4 hits
76
Uses testimonials to undermine the company's core value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory4 hits
79
Uses testimonials to contradict the company's marketing claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory4 hits
83
The slide uses testimonials from a former employee to frame management as incompetent and the product as obsolete.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory4 hits